Our portfolio includes recently-approved COPD therapy Duaklir®, which we plan to launch in H2 2019, and late-stage nitric oxide product AirNOvent.

COPD treatment


AirNOvent is a ventilator-compatible system that utilizes an electric voltage to produce precise quantities of nitric oxide from the nitrogen and oxygen in air.

In this section